NeoVolta, Inc. — Form 10-Q Summary
Reporting period: Fiscal first quarter, three months ended September 30, 2022; filed November 10, 2022. The company designs, manufactures, and sells residential and commercial energy storage systems, primarily through wholesale dealers and installers.
Key financial results
| Metric | Q1 FY2023 | Prior-year quarter |
|---|---|---|
| Revenue | $1.538 million | $1.600 million |
| Gross profit / margin | $246,000 / approximately 16% | $239,000 / approximately 15% |
| Operating expenses | $940,000 | $361,000 |
| Operating loss | $694,000 | $122,000 |
| Net loss | $699,000; $0.02 per share | $123,000; $0.01 per share |
| Net cash used in operations | $118,000 | $188,000 |
Cash and cash equivalents were $3.993 million at September 30, up from $330,000 at June 30. Working capital was approximately $7.47 million. Total liabilities were $343,000, with no convertible debt remaining after conversion in August. Assets consisted entirely of current assets, including $2.076 million in accounts receivable and $1.637 million in inventory.
Changes and notable transactions
- Revenue declined about 4% year over year. Management attributed the decrease to COVID-19 impacts and timing of orders from major dealers and installers.
- Gross margin increased approximately one percentage point, which management associated largely with differences in temporary tariffs on materials sourced from China.
- Net loss widened substantially, primarily as general and administrative expense rose to $919,000 from $357,000. The increase mainly reflected $580,000 of non-cash executive restricted-stock-unit compensation.
- An August underwritten offering generated approximately $3.78 million in net proceeds. The company issued 1,121,250 shares and warrants; outstanding shares increased to 32,770,368 at quarter-end from 21,977,251 at June 30.
- Convertible notes and accrued interest totaling approximately $1.13 million were converted into 9,671,867 shares, eliminating convertible debt.
Outlook, risks, and other disclosures
- Management said the offering proceeds were intended to support increased production capacity, product expansion, marketing and sales, and general corporate purposes. It expected cash resources to fund operations for at least 12 months from issuance of the financial statements and anticipated increasing product demand. The company cautioned that operating cash flow had only been roughly break-even at times and had not been sustained consistently. No quantified revenue or earnings guidance was provided.
- Management reported COVID-19-related sales effects and cited potential uncertainty involving operations, supply chains, energy demand, and commodity prices, while stating it did not then expect a material future adverse effect from COVID-19.
- Two wholesale dealers generated approximately 53% of quarterly revenue; three dealers accounted for approximately 62% of accounts receivable. Cash exceeding the FDIC-insured limit was $3.743 million.
- Disclosure controls were deemed ineffective because of a material weakness involving insufficient segregation of duties and a formal multi-level financial-reporting review process. Management said additional personnel would be needed to remediate the weakness. No material change in internal control over financial reporting was reported during the quarter.
- The company reported no material legal proceedings and no material changes to the risk factors in its June 30, 2022 Form 10-K. It reported no off-balance-sheet arrangements.
Important facts for investors to verify
- Whether revenue growth and positive operating cash flow can be sustained, given the quarter’s modest sales decline and management’s caveat about inconsistent break-even cash flow.
- How the public-offering proceeds are deployed and whether planned production and product expansion translate into sales and margins.
- The effects of dealer concentration, receivable collection, supply-chain exposure, and tariffs on operating results.
- Progress and timing of remediation of the material weakness in disclosure controls.
- Potential dilution from the offering warrants, underwriter warrants, and executive equity awards.